These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2996418)

  • 1. Azathioprine and steroids are not more effective in decreasing multiple sclerosis intra-blood-brain-barrier IgG synthesis than steroids alone.
    Staugaitis SM; Shapshak P; Myers LW; Ellison GW; Tourtellotte WW; Lee M
    Ann Neurol; 1985 Sep; 18(3):356-7. PubMed ID: 2996418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal methylprednisolone acetate in multiple sclerosis treatment. Clinical evaluation.
    Mazzarello P; Poloni M; Piccolo G; Cosi V; Pinelli P
    Acta Neurol Belg; 1983; 83(4):190-6. PubMed ID: 6689244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The basis of intra-blood-brain-barrier IgG synthesis.
    Tourtellotte WW; Staugaitis SM; Walsh MJ; Shapshak P; Baumhefner RW; Potvin AR; Syndulko K
    Ann Neurol; 1985 Jan; 17(1):21-7. PubMed ID: 3985581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of prednisone and azathioprine treatment on oligoclonal IGG in the cerebrospinal fluid of multiple sclerosis patients. Preliminary communication].
    Losy J; Karolewska J; Wender M
    Neurol Neurochir Pol; 1996; 30(2):201-11. PubMed ID: 8756247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid (CSF) parameters and clinical course of multiple sclerosis.
    Livrea P; Simone IL; Trojano M; Pisicchio L; Logroscino G; Rosato A
    Riv Neurol; 1987; 57(3):189-96. PubMed ID: 3672011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Steroid therapy in multiple sclerosis].
    Beer S; Kesselring J
    Schweiz Med Wochenschr; 1991 Jun; 121(26):961-9. PubMed ID: 1650496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of progressive and severe forms of multiple sclerosis using a combination of antilymphocyte serum, azathioprine and prednisone. Clinical and biological results. Comparison with a control group treated with azathioprine and prednisone only. 4-year follow-up].
    Lhermitte F; Marteau R; de Saxcé H
    Rev Neurol (Paris); 1987; 143(2):98-107. PubMed ID: 3299618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isotachophoresis quantitation of subfractions of multiple sclerosis intra-blood-brain barrier IgG synthesis modulated by ACTH and/or steroids.
    Tourtellotte WW; Potvin AR; Ma BI; Baumhefner RW; Walsh MJ; Dickstein P; Ingram T; Cowan T; Shapshak P; Delmotte P
    Neurology; 1982 Mar; 32(3):261-6. PubMed ID: 6278361
    [No Abstract]   [Full Text] [Related]  

  • 9. Intrathecal immunoglobulin synthesis in multiple sclerosis: effect of corticosteroids and azathioprine.
    Miró J; Aguayo F; Garrido JC; Alvarez C; Polo JM; Pascual J; Berciano J
    Eur Neurol; 1992; 32(6):349-53. PubMed ID: 1337041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Findings of cerebrospinal fluid in the diagnosis of multiple sclerosis].
    Drulović J; Stojsavljević N; Dujmović I; Sokić D; Mavra M; Lević Z
    Srp Arh Celok Lek; 1995; 123(7-8):191-3. PubMed ID: 17974427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azathioprine reduces intrathecal IgG synthesis in multiple sclerosis.
    Caputo D; Zaffaroni M; Ghezzi A; Cazzullo CL
    Acta Neurol Scand; 1987 Feb; 75(2):84-6. PubMed ID: 3577680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of ACTH therapy on IgG synthesis in cerebrospinal fluid spaces in patients with disseminated sclerosis].
    Wender M; Michałowska G; Wajgt A
    Neurol Neurochir Pol; 1986; 20(5):437-43. PubMed ID: 3035406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copolymer 1 as therapy for multiple sclerosis: the cons.
    Baumhefner RW; Tourtellotte WW; Syndulko K; Shapshak P; Osborne M; Rubinshtein G
    Neurology; 1988 Jul; 38(7 Suppl 2):69-72. PubMed ID: 3386845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of antiretroviral treatment on blood-brain barrier integrity and intrathecal immunoglobulin production in neuroasymptomatic HIV-1-infected patients.
    Abdulle S; Hagberg L; Gisslén M
    HIV Med; 2005 May; 6(3):164-9. PubMed ID: 15876282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Are there any changes in CSF IgG levels in multiple sclerosis treated for long periods with an immunosuppressive agent (azathioprine)?].
    Oger J; Cloarec L; Chatel M; Sabouraud O
    Nouv Presse Med; 1973 Feb; 2(7):443. PubMed ID: 4631717
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of azathioprine treatment on IgG subclasses in multiple sclerosis].
    Losy J; Michałowska-Wender G; Wender M
    Neurol Neurochir Pol; 1993; 27(1):39-44. PubMed ID: 8502358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined treatment with steroids and azathioprine in IgA nephropathy: design of a prospective randomised multicentre trial.
    Locatelli F; Pozzi C; Del Vecchio L; Andrulli S; Pani A; Fogazzi G; Altieri P; Ponticelli C
    J Nephrol; 1999; 12(5):308-11. PubMed ID: 10630693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Albumin and IGG in the CSF as demonstration of blood-brain barrier damage and of immune response within the CNS (author's transl)].
    Cognazzo A; Gerbino Promis PC; Grasso E
    Riv Patol Nerv Ment; 1981; 101(3):151-64. PubMed ID: 7256113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The immune status as an indicator for parameter-dependent therapy of multiple sclerosis?].
    Kuppe G; Schmidt RM; Ludewig R
    Nervenarzt; 1989 Sep; 60(9):549-52. PubMed ID: 2812159
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic trials of multiple sclerosis and intrathecal IgG production.
    Wender M; Tokarz E; Michalowska G; Wajgt A
    Ital J Neurol Sci; 1986 Apr; 7(2):205-8. PubMed ID: 3013800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.